|
Search concepts
|
| Selected Filters |
Search results
-
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma
Cohen, S. J., Zalupski, M. M., Conkling, P., Nugent, F., Ma, W. W., Modiano, M., Pascual, R., Lee, F. C., Wong, L. & Hersh, E., Jan 1 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 3, p. 230-235 6 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
Hersh, E. M., O'Day, S. J., Powderly, J., Khan, K. D., Pavlick, A. C., Cranmer, L. D., Samlowski, W. E., Nichol, G. M., Yellin, M. J. & Weber, J. S., Jun 1 2011, In: Investigational New Drugs. 29, 3, p. 489-498 10 p.Research output: Contribution to journal › Article › peer-review
224 Scopus citations -
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma
Hersh, E. M., Del Vecchio, M., Brown, M. P., Kefford, R., Loquai, C., Testori, A., Bhatia, S., Gutzmer, R., Conry, R., Haydon, A., Robert, C., Ernst, S., Homsi, J., Grob, J. J., Kendra, K., Agarwala, S. S., Li, M., Clawson, A., Brachmann, C., Karnoub, M. & 3 others, , Nov 2015, In: Annals of Oncology. 26, 11, p. 2267-2274 8 p., mdv324.Research output: Contribution to journal › Article › peer-review
33 Scopus citations -
Ipilimumab pharmacotherapy in patients with metastatic melanoma
Jeter, J. M., Cranmer, L. D. & Hersh, E. M., 2012, In: Clinical Medicine Insights: Oncology. 6, p. 275-286 12 p.Research output: Contribution to journal › Review article › peer-review
8 Scopus citations